Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update.
Sign Up to like & getrecommendations! Published in 2023 at "Seminars in nuclear medicine"
DOI: 10.1053/j.semnuclmed.2022.12.006
Abstract: Systemic radioimmunotherapy (RIT) is arguably the most effective and least toxic anticancer treatment for non-Hodgkin lymphoma (NHL). In treatment-naïve patients with indolent NHL, the efficacy of a single injection of RIT compares with that of… read more here.
Keywords: non hodgkin; lymphoma; radioimmunotherapy non; rit ... See more keywords